Oncology
Myeloma Survival Unchanged With Longer Lenalidomide
In ENDURANCE, indefinite lenalidomide maintenance did not improve 7-year overall survival versus a fixed 2-year course for standard-risk myeloma managed without upfront transplant.
Rayan Salih · August 28, 2026 · 6 min